Aptinyx

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Aptinyx and other ETFs, options, and stocks.

About APTX

Aptinyx Inc. is a clinical stage biopharmaceutical company, which engages in discovery, development, and commercialization of transformative therapies for disorders of the brain and nervous system. Its product includes NYX-2925, NYX-783, NYX-458, and the AGN-241751 program.

CEO

Andrew Kidd

CEOAndrew Kidd

Employees

Employees40

Headquarters

Evanston, Illinois

HeadquartersEvanston, Illinois

Founded

2015

Founded2015

Employees

Employees40

APTX Key Statistics

Market cap

19.39M

Market cap19.39M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

174.29K

Average volume174.29K

High today

$0.2902

High today$0.2902

Low today

$0.2704

Low today$0.2704

Open price

$0.2752

Open price$0.2752

Volume

43.73K

Volume43.73K

52 Week high

$3.76

52 Week high$3.76

52 Week low

$0.20

52 Week low$0.20

Analyst ratings

57%

of 7 ratings

Buy

57.1%

Hold

42.9%

Sell

APTX Earnings

-$0.35

-$0.23

-$0.12

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 22, After Hours

ActualExpected Mar 22, After Hours